Early Age-Related HearingLoss Investigation (EARHLI) is a study to obtain information on how a hearing aid-based intervention can prevent cognitive decline in those at risk for Alzheimer's Disease and…
Early Age-Related HearingLoss Investigation (EARHLI) is a study to obtain information on how a hearing aid-based intervention can prevent cognitive decline in those at risk for Alzheimer's Disease and…
The purpose of this study is to learn more about the mechanisms of hearingloss, specifically to learn how abnormalities in the brain may produce certain experiences that are common in patients with hearing…
Cisplatin is a chemotherapy medicine that is used to treat a variety of cancers. At high total (cumulative) doses it can be associated with progressive and irreversible hearingloss. The purpose of this study is see if injections of OTO-104 can protect against hearing…
The purpose of this research is to find out whether it is safe to use a virus to deliver a new gene to the inner ear of people with hearingloss. This is a kind of gene therapy which involves gene transfer. Once the genetic material…
For over 30 years, The Columbia University Alzheimer's Disease Research Center (ADRC) has worked with thousands of participants who have helped provide important insights into how the brain ages and why Alzheimer's disease may develop. We are actively recruiting adults 65 y…
This is a research study for persons with memory problems that examines the utility of performing positron emission tomography (PET) scans for the brain amyloid protein found in Alzheimer's disease.